Literature DB >> 29845300

miRNA‑195 suppresses cell proliferation of ovarian cancer cell by regulating VEGFR2 and AKT signaling pathways.

Jun Chen1.   

Abstract

The present study aimed to investigate the functional effects of microRNA‑195 on ovarian cancer cells and the underling mechanism involved. Reverse transcription‑quantitative polymerase chain reaction was used to measure the expression of microRNA‑195 in patients with ovarian cancer. Cell proliferation and apoptosis were measured with MTT assay and flow cytometry, respectively. Caspase‑3/9 activity, vascular endothelial growth factor receptor (VEGFR)2 and phosphorylated protein kinase B (p‑AKT) protein expression were analyzed using caspase‑3/9 activity kits and western blot analysis. The expression of microRNA‑195 was downregulated in ovarian cancer, compared with the normal control group. Furthermore, microRNA‑195 suppresses cell proliferation and induced apoptosis of ovarian cancer cells. In addition, microRNA‑195 suppressed VEGFR2 and p‑AKT protein expression in ovarian cancer cells. The inhibition of VEGFR2 and p‑AKT increased the functional effects of microRNA‑195 on apoptosis of ovarian cancer cells. The results demonstrated that microRNA‑195 suppresses cell proliferation of ovarian cancer cells through regulation of VEGFR2 and AKT signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29845300     DOI: 10.3892/mmr.2018.9098

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

Review 1.  Targeting Akt-associated microRNAs for cancer therapeutics.

Authors:  Mir S Adil; Daulat Khulood; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-12-24       Impact factor: 6.100

2.  MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway.

Authors:  Xiaoying Hao; Qingqing Jia; Jieling Yuan; Xiangrong Shi; Huihui Guo; Jiefang Gao; Ye Guo
Journal:  Int J Mol Med       Date:  2020-08-31       Impact factor: 4.101

3.  VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis.

Authors:  Hao Ni; Min Guo; Xuepei Zhang; Lei Jiang; Shuai Tan; Juan Yuan; HuanhuanL Cui; Yanan Min; Junhao Zhang; Susanne Schlisio; Chunhong Ma; Wangjun Liao; Monica Nister; Chunlin Chen; Shuijie Li; Nailin Li
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.